The crucial roles of long noncoding RNA SNHGs in lung cancer

• Feng Chen ^[1] ; Fa Zhang ^[2] ; Yu-fang Leng ^[1] ; Ya-jing Shi ^[1] ; Jian-ming Zhang ^[1] ; Yong-qiang Liu ^[1]
  1. [1] First Hospital of Lanzhou University

     First Hospital of Lanzhou University

     China

     
  2. [2] Gansu Provincial Hospital

     Gansu Provincial Hospital

     China

     
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 24, Nº. 12 (December), 2022, págs. 2272-2284
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Lung cancer is one of the most common malignant tumors with growing morbidity and mortality worldwide. Several treatments are used to manage lung cancer, including surgery, radiotherapy and chemotherapy, as well as molecular-targeted therapy. However, the current measures are still far from satisfactory. Therefore, the current research should focus on exploring the molecular mechanism and then finding an effective treatment. Interestingly, we and others have embarked on a line of investigations focused on the mechanism of lung cancer. Specifically, lncRNA small nucleolar RNA host gene has been shown to be associated with biological characteristics and therapeutic resistance of lung cancer. In addition, small nucleolar RNA host genes may be used as diagnostic biomarker in the future. Herein, we will provide a brief review demonstrating the importance of small nucleolar RNA host genes in lung cancer, especially non-small cell lung cancer. Although lncRNA has shown a crucial role in tumor-related research, a large number of studies are needed to validate its clinical application in the future.